Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus

Neurosurgical Focus

Volumn 34, Issue 6, 2013, Pages

  Juhász, Csaba ^a,b,c,d   Buth, Amy ^b,d   Chugani, Diane C ^a,c   Kupsky, William J ^b,d   Chugani, Harry T ^a,b,c   Shah, Aashit K ^b   Mittal, Sandeep ^b,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^d KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Alpha 11C methyl L tryptophan; Epilepsy surgery; Indoleamine 2,3 dioxygenase; Inflammation; Interleukin 1 ; Molecular imaging; New onset refractory status epilepticus; Positron emission tomography; Refractory status epilepticus

Indexed keywords

CARBON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; TRYPTOPHAN; TRYPTOPHAN METHYL ESTER; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ANALOGS AND DERIVATIVES; CASE REPORT; COMPLICATION; DIAGNOSTIC USE; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EPILEPTIC STATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; SCINTISCANNING; TEMPORAL LOBE; ARTICLE; METHODOLOGY;

CARBON RADIOISOTOPES; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERLEUKIN-1BETA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGERY; POSITRON-EMISSION TOMOGRAPHY; STATUS EPILEPTICUS; TEMPORAL LOBE; TRYPTOPHAN;

EID: 84879115932     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2013.3.FOCUS1336     Document Type: Article

References (26)

1. Asano E, Chugani DC, Muzik O, Shen C, Juhász C, Janisse J, et al: Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54:1976-1984, 2000
2. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, et al: Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78:7-21, 2008
3. Chugani DC: a-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomarkers Med 5:567-575, 2011
4. Chugani DC, Chugani HT, Muzik O, Shah JR, Shah AK, Canady A, et al: Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44:858- 866, 1998
5. Chugani DC, Muzik O: Alpha[C-11]methyl-L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 20:2-9, 2000
6. Chugani HT, Kumar A, Kupsky W, Asano E, Sood S, Juhász C: Clinical and histopathologic correlates of 11C-alpha-methyl- L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia 52:1692-1698, 2011
7. Dedeurwaerdere S, Friedman A, Fabene PF, Mazarati A, Murashima YL, Vezzani A, et al: Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 53:1113-1118, 2012
8. Diksic M, Nagahiro S, Sourkes TL: Biological model for the in vivo measurement of rate of serotonin synthesis in the brain. J Neural Transm Suppl 29:131-140, 1990
9. Heyes MP: The kynurenine pathway and neurologic disease. Therapeutic strategies. Adv Exp Med Biol 398:125-129, 1996
10. Hissong BD, Byrne GI, Padilla ML, Carlin JM: Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1. Cell Immunol 160:264-269, 1995
11. Ismail FY, Kossoff EH: AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia 52:e185- e189, 2011
12. Iyer A, Zurolo E, Spliet WG, van Rijen PC, Baayen JC, Gorter JA, et al: Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51: 1763-1773, 2010
13. Jacobs AH, Tavitian B: Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab 32:1393-1415, 2012
14. Juhász C, Chugani DC, Muzik O, Shah A, Asano E, Mangner TJ, et al: Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60:960-968, 2003
15. Juhász C, Chugani DC, Muzik O, Wu D, Sloan AE, Barger G, et al: In vivo uptake and metabolism of alpha-[11C]methyl- L-tryptophan in human brain tumors. J Cereb Blood Flow Metab 26:345-357, 2006
16. Kamson DO, Juhász C, Buth A, Kupsky WJ, Barger GR, Chakraborty PK, et al: Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates. J Neurooncol 112:121-132, 2013
17. Körtvelyessy P, Lerche H, Weber Y: FIRES and NORSE are distinct entities. Epilepsia 53:1276, 2012
18. Librizzi L, Noè F, Vezzani A, de Curtis M, Ravizza T: Seizureinduced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 72:82-90, 2012
19. Maldonado M, Baybis M, Newman D, Kolson DL, Chen W, McKhann G II, et al: Expression of ICAM-1, TNF-alpha, NF kappa B, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis 14:279-290, 2003
20. Nabbout R, Vezzani A, Dulac O, Chiron C: Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 10:99-108, 2011
21. O'Connor JC, André C, Wang Y, Lawson MA, Szegedi SS, Lestage J, et al: Interferon-gamma and tumor necrosis factoralpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29:4200- 4209, 2009
22. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, et al: The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24:128-143, 2006
23. Tohyama Y, Yamane F, Fikre Merid M, Blier P, Diksic M: Effects of serotine receptors agonists, TFMPP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J Neurochem 80:788-798, 2002
24. Vezzani A, Balosso S, Ravizza T: The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22:797- 803, 2008
25. Vezzani A, French J, Bartfai T, Baram TZ: The role of inflammation in epilepsy. Nat Rev Neurol 7:31-40, 2011
26. Wilder-Smith EP, Lim EC, Teoh HL, Sharma VK, Tan JJ, Chan BP, et al: The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore 34:417-420, 2005